Education
About Us
Working with TipRanks
Follow Us
Stacy J. Kanter Insider Profile
4 Followers
Stacy J. Kanter, Director at Applied Therapeutics, holds 65.00K shares in Applied Therapeutics (Ticker: APLT), holds 4.50K shares in Oppenheimer Holdings (Ticker: OPY). Most recently, Stacy J. Kanter Sold ― shares of Applied Therapeutics on Dec 18, 2025 for an estimated value of $4.73K.
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-43.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Stacy J. Kanter holds in companies
Most Profitable Insider Trade
The most profitable trade made by Stacy J. Kanter
Stacy J. Kanter's Trading History
Applied Therapeutics
Dec 18, 2025
Director
Informative Sell
4.73K
$6.50K
Oppenheimer Holdings
Jan 31, 2025
Director
Uninformative Buy
―
$330.75K
List of latest transactions for each holding click on a transaction to see Stacy J. Kanter's performance on stock
You May Also Like
Stacy J. Kanter insider profile FAQ
What is the percentage of profitable transactions made by Stacy J. Kanter?
The percentage of profitable transactions made by Stacy J. Kanter is 25%.
What is the average return per transaction made by Stacy J. Kanter?
The average return per transaction made by Stacy J. Kanter is -43.60%.
What stocks does Stacy J. Kanter hold?
Stacy J. Kanter holds: APLT, OPY stocks.
What was Stacy J. Kanter’s latest transaction?
Stacy J. Kanter latest transaction was an Informative Sell of $4.73K.
What was Stacy J. Kanter's most profitable transaction?
Stacy J. Kanter’s most profitable transaction was an Informative Sell of APLT stock on December 18, 2025. The return on the trade was 18.60%.
What is Stacy J. Kanter's role in Applied Therapeutics?
Stacy J. Kanter's role in Applied Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.